HIGHLIGHTS
- who: Influenza Other Respi Viruses. et al. from the Department of Immunology, Oslo University have published the paper: Prevalence of antibodies against SARSu2010CoVu20102 in the Norwegian population, August, in the Journal: (JOURNAL) of December/27,/2020
- what: In this nationwide cross-sectional seroprevalence study based on residual sera collected in Norway in August 2021, the authors report a high overall seroprevalence estimate from vaccination and/or infection of 62.6% (95% CrI 60.1%-65.2%). The authors report an estimated prevalence of SARS-CoV-2 antibodies (com- dren illustrates the limitations of using antibodies . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.